These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 5733089)
21. Dimethyl sulfoxide. Controversy and current status--1981. Council on scientific affairs. JAMA; 1982 Sep; 248(11):1369-71. PubMed ID: 7109159 [No Abstract] [Full Text] [Related]
22. FDA Arthritis Advisory Committee meeting: methotrexate; guidelines for the clinical evaluation of antiinflammatory drugs; DMSO in scleroderma. Paulus HE Arthritis Rheum; 1986 Oct; 29(10):1289-90. PubMed ID: 3768061 [No Abstract] [Full Text] [Related]
23. Dimethyl sulfoxide: a review of its use in the rheumatic disorders. Trice JM; Pinals RS Semin Arthritis Rheum; 1985 Aug; 15(1):45-60. PubMed ID: 3898376 [No Abstract] [Full Text] [Related]
24. Lack of ocular changes with dimethyl sulfoxide therapy of scleroderma. Shirley HH; Lundergan MK; Williams HJ; Spruance SL Pharmacotherapy; 1989; 9(3):165-8. PubMed ID: 2755866 [TBL] [Abstract][Full Text] [Related]
25. Dimethyl sulfoxide in the treatment of scleroderma. Engel MF South Med J; 1972 Jan; 65(1):71-3. PubMed ID: 5058095 [No Abstract] [Full Text] [Related]
26. Use of "DMSO" for unapproved indications. Crit Care Update; 1981 Apr; 8(4):24-5. PubMed ID: 6908552 [No Abstract] [Full Text] [Related]
27. Indications and contraindications for the use of DMSO in clinical dermatology. Engel MF Ann N Y Acad Sci; 1967 Mar; 141(1):638-45. PubMed ID: 5233139 [No Abstract] [Full Text] [Related]
28. The effect of percutaneous dimethyl sulfoxide on cutaneous manifestations of systemic sclerosis. Scherbel AL Ann N Y Acad Sci; 1983; 411():120-30. PubMed ID: 6576688 [TBL] [Abstract][Full Text] [Related]
29. Current developments in rheumatology in the Soviet Union. Nassonova VA Arthritis Rheum; 1988 Jan; 31(1):140-4. PubMed ID: 3257871 [No Abstract] [Full Text] [Related]
30. [Current approaches to the treatment of patients with systemic scleroderma]. Huĭda PP Lik Sprava; 1998; (1):122-6. PubMed ID: 9621636 [TBL] [Abstract][Full Text] [Related]
31. [Dimethylsulfoxide in the treatment of organic forms of scleroderma]. Sergeev VP Sov Med; 1975 Aug; (8):154-5. PubMed ID: 1233753 [No Abstract] [Full Text] [Related]
32. [Griseofulvin in the treatment of circumscribed scleroderma]. Capusan I; Pop OM; Pop CS Dermatologica; 1966; 132(4):337-42. PubMed ID: 5958880 [No Abstract] [Full Text] [Related]
33. [The local therapy of systemic scleroderma]. Guseva NG Ter Arkh; 1990; 62(5):110-3. PubMed ID: 2396204 [No Abstract] [Full Text] [Related]
34. [Treatment with Chelaton Polfa of circumscribed scleroderma in a child]. Niewiedziol B; Malczyńska E Pol Tyg Lek; 1968 Sep; 23(39):1487-8. PubMed ID: 4972439 [No Abstract] [Full Text] [Related]
35. [Dimethyl sulfoxide (DMSO) in the therapy of scleroderma]. Tadić-Tigerman V Med Arh; 1970; 24(3):25-36. PubMed ID: 5524749 [No Abstract] [Full Text] [Related]
36. Dimethyl sulfoxide therapy in the treatment of vesicant extravasation: two case presentations. St Germain B; Houlihan N; D'Amato S J Intraven Nurs; 1994; 17(5):261-6. PubMed ID: 7965372 [TBL] [Abstract][Full Text] [Related]
37. Outcome measurement in scleroderma clinical trials. Pope JE; Bellamy N Semin Arthritis Rheum; 1993 Aug; 23(1):22-33. PubMed ID: 8235663 [TBL] [Abstract][Full Text] [Related]
38. [Prognosis and treatment of scleroderma]. Crickx B; Belaich S Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058 [TBL] [Abstract][Full Text] [Related]
39. Medical grand rounds from the University of Alabama Medical Center. South Med J; 1966 Nov; 59(11):1320-6. PubMed ID: 4959332 [No Abstract] [Full Text] [Related]
40. The spectrophotometric study of the binding of vitamin E to water + dimethyl sulfoxide and water + diethyl sulfoxide containing reversed micelles. Markarian SA; Grigoryan JD; Sargsyan HR Int J Pharm; 2008 Apr; 353(1-2):52-5. PubMed ID: 18155372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]